Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -158,133 | -520,118 | -445,724 | -407,196 | -307,622 |
| Depreciation Amortization | 23,359 | 20,451 | 18,392 | 13,917 | 9,933 |
| Accounts receivable | 93,754 | -98,980 | 50,320 | 24,590 | -45,000 |
| Accounts payable and accrued liabilities | 14,060 | -50,201 | 25,850 | 1,805 | -4,348 |
| Other Working Capital | 20,121 | -71,321 | 187,209 | 161,914 | -21,464 |
| Other Operating Activity | -137,194 | 326,893 | -37,328 | 6,505 | 145,496 |
| Operating Cash Flow | $-144,033 | $-393,276 | $-201,281 | $-198,465 | $-223,005 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,629,193 | 4,882,724 | 228,617 | 130,000 | 75,559 |
| PPE Investments | -14,105 | -20,084 | -20,927 | -42,193 | -45,746 |
| Purchase Sale Intangibles | N/A | -2,638 | -1,348 | -3,207 | -4,029 |
| Other Investing Activity | -2,465,632 | -4,769,854 | -284,782 | -282,790 | -53,982 |
| Investing Cash Flow | $-850,544 | $92,786 | $-77,092 | $-194,983 | $-24,169 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,716 | 795,245 | 380,572 | 628,082 | 463,549 |
| Other Financing Activity | -4,018 | -3,755 | -2,596 | -1,419 | 155,330 |
| Financing Cash Flow | $5,698 | $791,490 | $377,976 | $626,663 | $618,879 |
| Exchange Rate Effect | -2,085 | 682 | -2,510 | 34 | 620 |
| Beginning Cash Position | 1,277,713 | 786,031 | 688,938 | 455,689 | 83,364 |
| End Cash Position | 286,749 | 1,277,713 | 786,031 | 688,938 | 455,689 |
| Net Cash Flow | $-990,964 | $491,682 | $97,093 | $233,249 | $372,325 |
| Free Cash Flow | |||||
| Operating Cash Flow | -144,033 | -393,276 | -201,281 | -198,465 | -223,005 |
| Capital Expenditure | -14,105 | -20,084 | -20,927 | -42,197 | -45,747 |
| Free Cash Flow | -158,138 | -413,360 | -222,208 | -240,662 | -268,752 |